(Q36889289)

16 August 2017

title

Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients (English)

1 reference

16 August 2017

1 reference

11

Barry D Kahan

1 reference

16 August 2017

Richard J Knight

1

1 reference

16 August 2017

Martin Villa

2

1 reference

16 August 2017

Robert Laskey

3

1 reference

16 August 2017

Carlos Benavides

4

1 reference

16 August 2017

Linda Schoenberg

5

1 reference

16 August 2017

Maria Welsh

6

1 reference

16 August 2017

Ronald H Kerman

7

1 reference

16 August 2017

Hemangshu Podder

8

1 reference

16 August 2017

Charles T Van Buren

9

1 reference

16 August 2017

Stephen M Katz

10

1 reference

16 August 2017

publication date

1 July 2007

1 reference

16 August 2017

published in

Clinical Transplantation

1 reference

16 August 2017

volume

21

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

460-465

1 reference

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Rapamycin: clinical results and future opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Are wound complications after a kidney transplant more common with modern immunosuppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Improved freedom from rejection after a loading dose of sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00668.X

10.1111/J.1399-0012.2007.00668.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference